Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
DE Stocks

6L9.F stock up 2400% on XETRA 02 Mar 2026: high volume signals volatility

March 3, 2026
5 min read
Share with:

We saw 6L9.F stock jump 2400.00% on XETRA at market close on 02 Mar 2026 after a thin but intense volume burst. The price moved to EUR 0.025 from a prior close of EUR 0.001, on 3,500.00 traded shares, versus an average volume of 279.00. This high-volume move flags acute volatility and trading interest in ViewRay, Inc. (6L9.F) on the Germany XETRA market, and it requires close follow-up for both short-term traders and longer-term investors.

6L9.F stock trading and volume drivers

Today the main fact is the price surge to EUR 0.025 with intraday range EUR 0.001–0.025 and volume 3,500.00, a relative volume of 12.54. This single-price spike is the primary driver of the high-volume mover tag and explains the outsized percentage change.

Sponsored

We note the session is closed on 02 Mar 2026 on XETRA in Germany and the move came on light absolute liquidity. High relative volume on a low base creates large percent swings and short-term spreads.

Catalysts and company context for 6L9.F stock

ViewRay, Inc. (6L9.F) designs MRI-guided radiation therapy systems and sells the MRIdian platform to hospitals globally. The company lists corporate details and investor materials on its site source.

No formal news release was required to explain the spike; small-cap cross-list trading, block orders, or a technical squeeze can produce similar moves on XETRA.

Valuation and financials for 6L9.F stock

Key trailing metrics show an EPS of -0.55 and a negative PE of -0.05, with revenue per share 0.57 and book value per share 0.46. Market capitalization on XETRA reads EUR 207,228,256.00 and shares outstanding are 8,289,130,240.00.

Compared to the Healthcare sector average PE of 30.74, ViewRay’s negative profitability and stretched historical averages (50-day average EUR 0.32, 200-day average EUR 2.72) point to a high-risk valuation profile for the medical devices sub-industry.

Meyka AI rates 6L9.F with a score out of 100 and forecast

Meyka AI rates 6L9.F with a score of 61.52 out of 100 — Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects a short-term target of EUR 0.10 and a 12-month target of EUR 0.50 versus the current price EUR 0.025. That implies an upside of 300.00% to the short target and 1900.00% to the 12-month target. Forecasts are model-based projections and not guarantees.

Technicals, liquidity and 6L9.F stock risk

Technically the stock shows extreme short-term volatility: day high EUR 0.025, day low EUR 0.001, 50-day average EUR 0.32, 200-day average EUR 2.72. Average volume is low at 279.00, which magnifies price moves on modest orders.

Risk factors include negative operating margins, interest coverage weakness, and thin intraday liquidity on XETRA in Germany. Investors should expect wide spreads, rapid reversals, and execution risk.

Trading strategy and analyst view for 6L9.F stock

For high-volume mover trades we recommend position sizing limits and pick entries off confirmed momentum or meaningful news. Given the Meyka AI B grade and HOLD suggestion, a measured approach suits both traders and cautious investors.

Consider stop-loss levels and watch market cap and volume changes before scaling. For company details and filings consult ViewRay investor resources and the symbol image source.

Final Thoughts

The takeaway for 6L9.F stock after the XETRA close on 02 Mar 2026 is clear: the move to EUR 0.025 on 3,500.00 shares signals acute short-term volatility rather than a validated change in fundamentals. Meyka AI rates the name 61.52/100 (B) and projects a short-term model target of EUR 0.10 and a 12-month target of EUR 0.50, implying 300.00% and 1900.00% upside respectively from today’s price of EUR 0.025. These projections are model-based and not guarantees. Given weak profitability metrics, negative EPS -0.55, and limited daily liquidity, risk is elevated. We advise strict risk limits, use of stop orders, and close monitoring of news or block trades. For active traders, the high relative volume creates trading opportunities but also a high probability of rapid reversals on XETRA in Germany.

FAQs

Why did 6L9.F stock spike today?

The spike reflects a concentrated trading event on XETRA with volume 3,500.00 versus average 279.00, creating a large percentage move. Small-cap cross-listing and block trades often drive such sudden changes.

What is Meyka AI’s rating for 6L9.F stock?

Meyka AI rates 6L9.F 61.52/100 (B) with a HOLD suggestion. The grade balances sector comparison, financial metrics, and analyst signals, and is informational only.

What price targets exist for 6L9.F stock?

Meyka AI’s model projects EUR 0.10 (short term) and EUR 0.50 (12 months) versus current price EUR 0.025, implying 300.00% and 1900.00% upside. Forecasts are projections, not guarantees.

Is 6L9.F stock liquid enough for large trades?

No. Average volume 279.00 and today’s thin absolute volume mean execution risk is high for large orders on XETRA. Expect wide spreads and limit order use.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)